Access to anti-retroviral drugs, female in Saudi Arabia
Saudi Arabia: Access to anti-retroviral drugs, female was 91.0% in 2024. ▲ Rising
Access to anti-retroviral drugs, female in Saudi Arabia, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Saudi Arabia stood at 91.0%. That is the highest value across all 25 years on record.
The figure is up 4.6% on the previous year and up 46.8% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Saudi Arabia peaked at 91.0% in 2024 and was at its lowest, 12.0%, in 2000.
Saudi Arabia ranks 25th of 141 countries on this measure, in the top quarter.
The long-run direction has been consistently rising across the 25 years of available data.
Access to anti-retroviral drugs, female in Saudi Arabia, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 12.0% | — |
| 2001 | 14.0% | +16.7% |
| 2002 | 16.0% | +14.3% |
| 2003 | 19.0% | +18.8% |
| 2004 | 21.0% | +10.5% |
| 2005 | 25.0% | +19.0% |
| 2006 | 28.0% | +12.0% |
| 2007 | 32.0% | +14.3% |
| 2008 | 36.0% | +12.5% |
| 2009 | 40.0% | +11.1% |
| 2010 | 45.0% | +12.5% |
| 2011 | 47.0% | +4.4% |
| 2012 | 49.0% | +4.3% |
| 2013 | 53.0% | +8.2% |
| 2014 | 62.0% | +17.0% |
| 2015 | 70.0% | +12.9% |
| 2016 | 71.0% | +1.4% |
| 2017 | 75.0% | +5.6% |
| 2018 | 76.0% | +1.3% |
| 2019 | 77.0% | +1.3% |
| 2020 | 78.0% | +1.3% |
| 2021 | 78.0% | +0.0% |
| 2022 | 82.0% | +5.1% |
| 2023 | 87.0% | +6.1% |
| 2024 | 91.0% | +4.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 24.3% | 12.0% | 40.0% | 10 |
| 2010s | 62.5% | 45.0% | 77.0% | 10 |
| 2020s | 83.2% | 78.0% | 91.0% | 5 |
Countries ranked near Saudi Arabia
- 22 France 93.0% compare
- 22 Malawi 93.0% compare
- 22 Morocco 93.0% compare
- 25 Denmark 91.0% compare
- 27 Ethiopia 90.0% compare
- 27 Haiti 90.0% compare
- 27 Ireland 90.0% compare
- 27 Kenya 90.0% compare
- 27 Romania 90.0% compare
- 27 Switzerland 90.0% compare
- 27 Tanzania, United Republic of 90.0% compare
- 27 Thailand 90.0% compare
More gender data for Saudi Arabia
- Child population (UN estimates and projections) 8,519 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.7629 % change on previous year (2030)
- Population 28,924 (2030)
- Working-age population (UN estimates and projections) 28,924 (2030)
- Population (UN estimates and projections), annual growth rate 1.65 % change on previous year (2030)
- Age population, age 00, female, interpolated 275,243 (2025)
- Age population, age 00, male, interpolated 288,722 (2025)
- Age population, age 01, female, interpolated 275,525 (2025)
- Age population, age 01, male, interpolated 288,548 (2025)
- Age population, age 02, female, interpolated 263,011 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Saudi Arabia?
- Access to anti-retroviral drugs, female in Saudi Arabia was 91.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Saudi Arabia?
- The highest recorded value was 91.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Saudi Arabia?
- The lowest recorded value was 12.0% in 2000.
- How does Saudi Arabia rank for access to anti-retroviral drugs, female?
- Saudi Arabia ranks 25th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Saudi Arabia?
- Over the last ten years it is up 46.8%. The long-run trend across the full record is rising.
- Where does this Saudi Arabia data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.